Items where authors include "Mavroudis, D"
Article
Dennis, J, Tyrer, JP, Walker, LC et al. (121 more authors) (2022) Rare germline copy number variants (CNVs) and breast cancer risk. Communications Biology, 5. 65. ISSN 2399-3642
Park, HA, Neumeyer, S, Michailidou, K et al. (274 more authors) (2021) Mendelian randomisation study of smoking exposure in relation to breast cancer risk. British Journal of Cancer, 125. pp. 1135-1145. ISSN 0007-0920
Morra, A, Escala-Garcia, M, Beesley, J et al. (175 more authors) (2021) Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment. Breast Cancer Research, 23 (1). 86.
Baxter, JS, Johnson, N, Tomczyk, K et al. (180 more authors) (2021) Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element. The American Journal of Human Genetics, 108 (7). pp. 1190-1203. ISSN 0002-9297
Johnson, N, Maguire, S, Morra, A et al. (145 more authors) (2021) CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers. British Journal of Cancer, 124 (4). pp. 842-854. ISSN 0007-0920
Kramer, I, Hooning, MJ, Mavaddat, N et al. (264 more authors) (2020) Breast cancer polygenic risk score and contralateral breast cancer risk. The American Journal of Human Genetics, 107 (5). pp. 837-848. ISSN 0002-9297
Feng, H, Gusev, A, Pasaniuc, B et al. (249 more authors) (2020) Transcriptome‐wide association study of breast cancer risk by estrogen‐receptor status. Genetic Epidemiology, 44 (5). pp. 442-468. ISSN 0741-0395
Escala-Garcia, M, Abraham, J, Andrulis, IL et al. (142 more authors) (2020) A network analysis to identify mediators of germline-driven differences in breast cancer prognosis. Nature Communications, 11 (1). 312.
Fachal, L, Aschard, H, Beesley, J et al. (338 more authors) (2020) Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes. Nature Genetics, 52 (1). pp. 56-73. ISSN 1061-4036
Shu, X, Wu, L, Khankari, NK et al. (203 more authors) (2019) Associations of obesity and circulating insulin and glucose with breast cancer risk : a Mendelian randomization analysis. International Journal of Epidemiology, 48 (3). pp. 795-806. ISSN 0300-5771
Gray, R, Bradley, R, Braybrooke, J et al. (164 more authors) (2019) Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials. The Lancet, 393 (10179). pp. 1440-1452. ISSN 0140-6736
Mavaddat, N, Michailidou, K, Dennis, J et al. (266 more authors) (2019) Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes. The American Journal of Human Genetics, 104 (1). pp. 21-34. ISSN 0002-9297
Early Breast Cancer Trialists' Collaborative Group (EBCTCG), Alberro, JA, Ballester, B et al. (596 more authors) (2018) Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials. The Lancet Oncology, 19 (1). pp. 27-39. ISSN 1470-2045